Skip to main content
. 2008 May;116(5):382–392. doi: 10.1111/j.1600-0463.2008.00957.x

TABLE 2.

Results of H4 acetylation in A2780 biopsies and tumors during belinostat treatment in vivo (Experiment 3)

A2780 H4 acetylation
Belinostat, 100 mg/kg i.v.
ID Pretreatment biopsy 1 hbiopsy 2 hbiopsy 3 hbiopsy 3 htumor 6 hbiopsy 6 htumor 24 htumor
Large tumors (1500–1800 mg)
235 Weak Strong Weak
234 Moderate Strong Moderate
226 Weak Strong Weak
365 Moderate Strong Moderate
232 Weak Strong Moderate
233 No No No
553 Weak Weak
Small tumors (300–400 mg)
227 Strong Weak
238 Strong Moderate
237 Strong Strong
231 Strong
225 Moderate Moderate
236 Strong Moderate
228 Strong Weak
230 Weak Weak
552 No

Strong H4 acetylation is observed in biopsies collected 1 and 2 h after treatment. In most samples, acetylation is decreased after 3 h to a level similar to that observed in the pretreatment biopsies. Only weak acetylation is observed 6 h after treatment. (–, missing).